npca-annual-report-2021

Published by:
Healthcare Quality Improvement Partnership
Last updated:
26 January 2022
Topic:
Health
Licence:
Creative Commons Attribution

Summary

In the 2021 Annual Report, we present the results for patients diagnosed between 1st April 2019 and 31st March 2020 in England and Wales including: 1. The participation of NHS providers and the completeness and quality of the data submitted to the National Cancer Registration and Analysis Service (NCRAS), Public Health England and the Wales Cancer Network, Public Health Wales. 2. Patient demographic information and key aspects of the diagnostic and staging process they underwent and the treatments they received . 3. Treatment outcomes (up to two years post-treatment) for men in England and Wales undergoing radical prostatectomy (RP) or radical external beam radiotherapy (EBRT) in 2018. 4. The variation in treatment for men with low-risk, localised disease and high-risk/locally advanced disease in Wales only. In addition, we also present: 5. The impact of COVID-19 on the diagnosis of prostate cancer, receipt of radical treatment and systemic therapy in England only.

Individual provider results and reports are available enabling regional and national comparisons to support local QI. https://www.npca.org.uk/provider-results/

More from this publisher

All datasets from Healthcare Quality Improvement Partnership

Related datasets

Search

Data links

Link to the data Format File added Data preview
NPCA AR2021_Open data fields XLSX 26 January 2022 Not available
NPCA AR2021_Open data ODS 26 January 2022 Not available

Supporting documents

Link to the document Format Date added
NPCA Annual Report 2021 PDF 26 January 2022

Contact

Enquiries

Healthcare Quality Improvement Partnership

Freedom of Information (FOI) requests

Healthcare Quality Improvement Partnership Freedom of information requests for this dataset

Edit this dataset

You must have an account for this publisher on data.gov.uk to make any changes to a dataset.

Sign in